2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone has been researched along with Angiogenesis, Pathologic in 1 studies
2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone: ubiquinol analog
6-decylubiquinone : A member of the class of 1,4-benzoquinones that is 2,3-dimethoxybenzoquinone which has been substituted at positions 5 and 6 by decyl and methyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J | 1 |
| Liu, X | 1 |
| Yang, Y | 1 |
| Wei, B | 1 |
| Li, Q | 1 |
| Mao, G | 1 |
| He, Y | 1 |
| Li, Y | 1 |
| Zheng, L | 1 |
| Zhang, Q | 1 |
| Li, J | 1 |
| Wang, L | 1 |
| Qi, C | 1 |
1 other study available for 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Decylubiquinone suppresses breast cancer growth and metastasis by inhibiting angiogenesis via the ROS/p53/ BAI1 signaling pathway.
Topics: Animals; Breast Neoplasms; Chick Embryo; Female; Humans; MCF-7 Cells; Neoplasm Metastasis; Neoplasm | 2020 |